Focus on Peripheral Biomarkers of Mental Disorders
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Fernandes, B.S.; Williams, L.M.; Steiner, J.; Leboyer, M.; Carvalho, A.F.; Berk, M. The new field of ‘precision psychiatry’. BMC Med. 2017, 15, 80. [Google Scholar] [CrossRef] [PubMed]
- Ozomaro, U.; Wahlestedt, C.; Nemeroff, C.B. Personalized medicine in psychiatry: Problems and promises. BMC Med. 2013, 11, 132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Passos, I.C.; Ballester, P.; Rabelo-da-Ponte, F.D.; Kapczinski, F. Precision Psychiatry: The Future Is Now. Can. J. Psychiatry 2022, 67, 21–25. [Google Scholar] [CrossRef] [PubMed]
- Roffman, J.L. Biomarkers and personalized psychiatry. Harv. Rev. Psychiatry 2011, 19, 99–101. [Google Scholar] [CrossRef] [PubMed]
- Cuthbert, B.N.; Insel, T.R. Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med. 2013, 11, 126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Insel, T.R. The NIMH Research Domain Criteria (RDoC) Project: Precision medicine for psychiatry. Am. J. Psychiatry 2014, 171, 395–397. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelly, R.E., Jr.; Ahmed, A.O.; Hoptman, M.J.; Alix, A.F.; Alexopoulos, G.S. The Quest for Psychiatric Advancement through Theory, beyond Serendipity. Brain Sci. 2021, 12, 72. [Google Scholar] [CrossRef]
- Carvalho, A.F.; Solmi, M.; Sanches, M.; Machado, M.O.; Stubbs, B.; Ajnakina, O.; Sherman, C.; Sun, Y.R.; Liu, C.S.; Brunoni, A.R.; et al. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders. Transl. Psychiatry 2020, 10, 152. [Google Scholar] [CrossRef]
- Almulla, A.F.; Vasupanrajit, A.; Tunvirachaisakul, C.; Al-Hakeim, H.K.; Solmi, M.; Verkerk, R.; Maes, M. The tryptophan catabolite or kynurenine pathway in schizophrenia: Meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol. Psychiatry 2022, 1–13. [Google Scholar] [CrossRef]
- Bartoli, F.; Misiak, B.; Callovini, T.; Cavaleri, D.; Cioni, R.M.; Crocamo, C.; Savitz, J.B.; Carrà, G. The kynurenine pathway in bipolar disorder: A meta-analysis on the peripheral blood levels of tryptophan and related metabolites. Mol. Psychiatry 2021, 26, 3419–3429. [Google Scholar] [CrossRef]
- Bartoli, F.; Misiak, B.; Crocamo, C.; Carrà, G. Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2020, 101, 109922. [Google Scholar] [CrossRef] [PubMed]
- Belbasis, L.; Köhler, C.A.; Stefanis, N.; Stubbs, B.; van Os, J.; Vieta, E.; Seeman, M.V.; Arango, C.; Carvalho, A.F.; Evangelou, E. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: An umbrella review of meta-analyses. Acta Psychiatr. Scand. 2018, 137, 88–97. [Google Scholar] [CrossRef] [PubMed]
- Dunleavy, C.; Elsworthy, R.J.; Upthegrove, R.; Wood, S.J.; Aldred, S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr. Scand. 2022. online ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Fraguas, D.; Díaz-Caneja, C.M.; Ayora, M.; Hernández-Álvarez, F.; Rodríguez-Quiroga, A.; Recio, S.; Leza, J.C.; Arango, C. Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophr. Bull. 2019, 45, 742–751. [Google Scholar] [CrossRef]
- Misiak, B.; Bartoli, F.; Carrà, G.; Małecka, M.; Samochowiec, J.; Jarosz, K.; Banik, A.; Stańczykiewicz, B. Chemokine alterations in bipolar disorder: A systematic review and meta-analysis. Brain Behav. Immun. 2020, 88, 870–877. [Google Scholar] [CrossRef]
- Misiak, B.; Bartoli, F.; Carrà, G.; Stańczykiewicz, B.; Gładka, A.; Frydecka, D.; Samochowiec, J.; Jarosz, K.; Hadryś, T.; Miller, B.J. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology 2021, 127, 105200. [Google Scholar] [CrossRef]
- Pinto, J.V.; Moulin, T.C.; Amaral, O.B. On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review. Neurosci. Biobehav. Rev. 2017, 83, 97–108. [Google Scholar] [CrossRef]
- Bartoli, F.; Burnstock, G.; Crocamo, C.; Carrà, G. Purinergic Signaling and Related Biomarkers in Depression. Brain Sci. 2020, 10, 160. [Google Scholar] [CrossRef] [Green Version]
- Berardelli, I.; Serafini, G.; Cortese, N.; Fiaschè, F.; O’Connor, R.C.; Pompili, M. The Involvement of Hypothalamus-Pituitary-Adrenal (HPA) Axis in Suicide Risk. Brain Sci. 2020, 10, 653. [Google Scholar] [CrossRef]
- Fabrazzo, M.; Zampino, R.; Vitrone, M.; Sampogna, G.; Del Gaudio, L.; Nunziata, D.; Agnese, S.; Santagata, A.; Durante-Mangoni, E.; Fiorillo, A. Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study. Brain Sci. 2020, 10, 483. [Google Scholar] [CrossRef]
- Fusar-Poli, L.; Natale, A.; Amerio, A.; Cimpoesu, P.; Grimaldi Filioli, P.; Aguglia, E.; Amore, M.; Serafini, G.; Aguglia, A. Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder. Brain Sci. 2021, 11, 58. [Google Scholar] [CrossRef] [PubMed]
- Maes, M.; Vojdani, A.; Galecki, P.; Kanchanatawan, B. How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia. Brain Sci. 2020, 10, 645. [Google Scholar] [CrossRef] [PubMed]
- Reginia, A.; Samochowiec, J.; Jabłoński, M.; Ferensztajn-Rochowiak, E.; Rybakowski, J.K.; Telesiński, A.; Tarnowski, M.; Misiak, B.; Ratajczak, M.Z.; Kucharska-Mazur, J. Markers of Regenerative Processes in Patients with Bipolar Disorder: A Case-control Study. Brain Sci. 2020, 10, 408. [Google Scholar] [CrossRef] [PubMed]
- Silva Ribeiro, J.; Pereira, D.; Salagre, E.; Coroa, M.; Santos Oliveira, P.; Santos, V.; Madeira, N.; Grande, I.; Vieta, E. Risk Calculators in Bipolar Disorder: A Systematic Review. Brain Sci. 2020, 10, 525. [Google Scholar] [CrossRef] [PubMed]
- Steardo, L., Jr.; Luciano, M.; Sampogna, G.; Carbone, E.A.; Caivano, V.; Di Cerbo, A.; Giallonardo, V.; Palummo, C.; Vece, A.; Del Vecchio, V. Clinical Severity and Calcium Metabolism in Patients with Bipolar Disorder. Brain Sci. 2020, 10, 417. [Google Scholar] [CrossRef] [PubMed]
- Vismara, M.; Girone, N.; Cirnigliaro, G.; Fasciana, F.; Vanzetto, S.; Ferrara, L.; Priori, A.; D’Addario, C.; Viganò, C.; Dell’Osso, B. Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview. Brain Sci. 2020, 10, 564. [Google Scholar] [CrossRef]
- Wollenhaupt-Aguiar, B.; Kapczinski, F.; Pfaffenseller, B. Biological Pathways Associated with Neuroprogression in Bipolar Disorder. Brain Sci. 2021, 11, 228. [Google Scholar] [CrossRef]
- Abbracchio, M.P.; Jacobson, K.A.; Müller, C.E.; Zimmermann, H. Professor Dr. Geoffrey Burnstock (1929–2020). Purinergic Signal. 2020, 16, 137–149. [Google Scholar] [CrossRef]
- Abbracchio, M.P. The history of the Purine Club: A tribute to Prof. Geoffrey Burnstock. Purinergic Signal. 2021, 17, 127–134. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bartoli, F.; Carrà, G. Focus on Peripheral Biomarkers of Mental Disorders. Brain Sci. 2022, 12, 756. https://doi.org/10.3390/brainsci12060756
Bartoli F, Carrà G. Focus on Peripheral Biomarkers of Mental Disorders. Brain Sciences. 2022; 12(6):756. https://doi.org/10.3390/brainsci12060756
Chicago/Turabian StyleBartoli, Francesco, and Giuseppe Carrà. 2022. "Focus on Peripheral Biomarkers of Mental Disorders" Brain Sciences 12, no. 6: 756. https://doi.org/10.3390/brainsci12060756